Join
Live feed
·
INSIDERFilingvia Quantisnow
Crescent Biopharma Inc. logo

SEC Form 4: Desouza Errol B was granted 3,588 shares, increasing direct ownership by 14% to 29,801 units

ByQuantisnow·Wall Street's wire, on your screen.
CBIO· Crescent Biopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CBIO (Crescent Biopharma Inc.) and more on Quantisnow.